SANA BIOTECHNOLOGY, INC.

Analyst Reco. Sana Biotechnology, Inc.

Equities

SANA

US7995661045

Market Closed - Nasdaq Other stock markets 16:00:00 2024-04-29 EDT			5-day change	1st Jan Change
9.08 ^USD	+4.13%		+14.50%	+122.55%

04-18	Sana Biotechnology, Inc. Announces Resignation of Douglas Williams as Executive Vice President and President, Research and Development	CI
04-09	Certain Restricted Stock Units of Sana Biotechnology, Inc. are subject to a Lock-Up Agreement Ending on 9-APR-2024.	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JMP Securities Adjusts Sana Biotechnology Price Target to $15 From $8, Maintains Market Outperform Rating	03-01	MT
HC Wainwright Upgrades Sana Biotechnology to Buy From Neutral, Price Target is $12	01-16	MT
JMP Securities Trims Price Target on Sana Biotechnology to $8 From $9, Maintains Market Outperform Rating	23-10-12	MT
JMP Securities Initiates Sana Biotechnology With Market Outperform Rating, Price Target is $9	23-09-25	MT
Citigroup Starts Sana Biotechnology at Buy With $8 Price Target	23-09-05	MT
TD Cowen Initiates Sana Biotechnology at Market Perform	23-08-14	MT
HC Wainwright Starts Sana Biotechnology at Neutral	23-05-02	MT
Analysis-Biotech IPOs to bloom with spotlight on startups with human trial data	23-02-13	RE
Morgan Stanley Adjusts Price Target on Sana Biotechnology to $13 From $15, Maintains Overweight Rating	23-01-24	MT
Morgan Stanley Lowers Sana Biotechnology's Price Target to $15 From $17, Maintains Overweight Rating	22-05-17	MT
Morgan Stanley Adjusts Sana Biotechnology's Price Target to $17 from $40, Keeps Overweight Rating	22-02-01	MT
SANA BIOTECHNOLOGY : JPMorgan Adjusts Price Target for Sana Biotechnology to $31 From $35, Maintains Neutral Rating	21-08-06	MT
SANA BIOTECHNOLOGY : Goldman Sachs Adjusts Price Target on Sana Biotechnology to $34 From $39, Maintains Neutral Rating	21-08-06	MT
SANA BIOTECHNOLOGY : JPMorgan Starts Sana Biotechnology at Neutral With $35 Price Target	21-03-01	MT
SANA BIOTECHNOLOGY : Morgan Stanley Starts Sana Biotechnology at Overweight With $40 Price Target	21-03-01	MT
SANA BIOTECHNOLOGY : Goldman Sachs Starts Sana Biotechnology at Neutral With $40 Price Target	21-03-01	MT
SANA BIOTECHNOLOGY : BofA Securities Starts Sana Biotechnology at Buy With $45 Price Target	21-03-01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer